Sponsored by VisionaryHealthConcepts  

(creators of www.freehivinfo.com)  

 

 

 

Hepatitis/HIV co-infection

 

 

CROI: Week 4 or 12 Response to PegIFN Predicts Sustained Response With HCV/HIV (Feb 28, 2008)

 

Liver Damaged By Too Much Fast Food And Too Little Exercise (Feb 15, 2008)

 

CROI: Successful hepatitis C treatment has long-term benefits for coinfected patients (Feb 6, 2008)

 

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection? (Feb 5, 2008)

 

CROI: Pegylated interferon maintenance therapy demonstrates no benefit in HIV/hepatitis C coinfected individuals (Feb 5, 2008)

 

CROI: Rapid Liver Fibrosis Progression in HIV Positive Men with Acute HCV Infection (Feb 5, 2008)

 

CROI: Fibrosis Status of HIV-HCV Coinfection Patients with Normal ALT Levels (Feb 5, 2008)

 

UNAIDS & WHO 'Correct' Swiss on Unprotected Sex (Feb 1, 2008)

 

CROI: Successful hepatitis C treatment has long-term benefits for coinfected patients (Feb 6, 2008)

 

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection? (Feb 5, 2008)

 

CROI: Pegylated interferon maintenance therapy demonstrates no benefit in HIV/hepatitis C coinfected individuals (Feb 5, 2008)

 

CROI: Rapid Liver Fibrosis Progression in HIV Positive Men with Acute HCV Infection (Feb 5, 2008)

 

 

CROI: Fibrosis Status of HIV-HCV Coinfection Patients with Normal ALT Levels (Feb 5, 2008)

 

Treatment of Patients with HIV-HCV Coinfection: An Overview

 

Insulin Resistance Prevents Response to Peinterferon in Coinfection, study reports (Jan 29, 2008)
 

Accelerated Liver Disease Progression in HIV-HCV Coinfected Patients May Be Due to Increased Liver Inflammation (Jan 11, 2008)

 

Hepatitis B Revaccination Effective in People With HIV (Jan 9, 2008)

 

Frequent Occurrence of Chronic Hepatitis B Virus Infection among West African HIV Type-1-Infected Children (Jan 3, 2008)

 

Good Response to Hepatitis C Treatment in Patients with a History of Psychiatric Conditions (Dec 11, 2007)

 

Do HIV/HCV coinfected have worse neurocognitive function (Nov 30, 2007)

 

Liver cirrhosis in co-infected: prognosis poor, but improved by HAART  (Nov 8, 2007)

 

Natural History of Compensated Viral Cirrhosis in a Cohort of Patients With HIV Infection (Nov 2007)

 

Liver fibrosis often progresses rapidly in HIV/HCV co-infected; elevated AST levels best predictor (Oct 19, 2007)

 

HIV-positive patients who aren't tested for HCV have an increased risk of death (Sep 27, 2007)

 

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death (Aug 23, 2007)

 

HCV viral load before therapy associated with post-treatment relapse in HIV/HCV coinfected (Aug 23, 2007)

 

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death (Aug 23, 2007)

 

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis (Aug 14, 2007)

 

IAS: Atazanavir safe and effective in HCV-coinfected patients with cirrhosis (Aug 14, 2007)

 

IAS: HCV therapy does not significantly effect immune recovery of patients taking HIV therapy (Aug 6, 2007)

 

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C (Jul 24, 2007)

 

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men (Jul 24, 2007)

 

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C (Jul 24, 2007)

 

Tenofovir provides an effective long-term treatment for hepatitis B in HIV-positive patients (Jun 12, 2007)

 

France: Hepatic steatosis widespread among HIV/HCV coinfected patients in France (Jun 12, 2007)

 

No single drug associated with cryptogenic liver disease (Jun 12, 2007)

DDW: Adequate Doses of Ribavirin Are Critical for Achievement of Early Virological Response in HIV-HCV Coinfected Patients (May 25, 2007)

 

DDW: Alcohol Use Linked to Worse Liver Disease Progression in HIV-HCV Coinfected Patients (May 25. 2007)

 

Isolated Hepatitis B Core Antibody Is Commonly Associated with Viral Coinfection (May15, 2007)

 

Hepatitis C infection increases lymphoma risk (May 9, 2007)

 

Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents (Apr 30, 2007)

Download the full supplement alone or with the complete Adult Guidelines in PDF or PDA format

 

 

Treatment of HBV or HCV in triple-infected individuals not seen to cause rebound of untreated virus (Apr 23, 2007)

 

Resistance to New HCV Antivirals  (Apr 17, 2007)

 

Viral Hepatitis (HCV, HBV) in HIV Infection REVIEW by Margaret Koziel, Marion Peters - (Apr 9, 2007)

 

Standard screening tests may not detect hidden hepatitis B virus in HIV/HBV-coinfected patients (Mar 29, 2007)

 

HIV/hepatitis B coinfection: closer treatment monitoring needed?  (Mar 28, 2007)

 

Meta-analysis confirms hepatitis C vertical transmission more likely with coinfected mothers (Mar 27, 2007)

 

CROI: Anti-HBV drug entecavir also active against HIV and promotes antiretroviral resistance (Mar 2, 2007)

 

Predictive Value of Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients Treated With an Interferon-Based Regimen Plus Ribavirin  (Feb 23, 2007)

 

SVR Improved Quality of Life & Sexual Function in Patients with Advanced Fibrosis in HALT-C Study  (Feb 20, 2007)

 

Predictive Value of Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients Treated With an Interferon-Based Regimen Plus Ribavirin  (Feb 23, 2007)

 

SVR Improved Quality of Life & Sexual Function in Patients with Advanced Fibrosis in HALT-C Study  (Feb 20, 2007)

 

Lower risk of elevated cholesterol for HIV/HCV coinfected patients (Feb 8. 2007)

 

New cause of chronic liver disease identified in HIV-positive patients  (Jan 22, 2007)

 

Risk factors for false-negative HCV antibody tests in HIV-positive individuals identified

(Jan 22, 2007)

 

 

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests (12/15/2006)

 

Siblings of HIV/HCV coinfected patients also have higher mortality risk (12/14/2006)

 

Glasgow: Weight-based ribavirin dosing achieves high success rates in hepatitis C/HIV co-infected patients (11/21/2006)

 

AASLD: Does prior use of protease inhibitors (PIs) for HIV therapy affect response to experimental HCV PIs? (11/14/2006)

 

AASLD: Serum Markers for Assessment of Liver Fibrosis in HIV-HCV Coinfected Patients  (11/10/2006)

Histological Response to Pegylated Interferon plus Ribavirin in HIV-HCV Coinfected Individuals (11/10/2006)

 

Outcomes in HIV-HBV Coinfected Patients Treated with Drugs Active Against Both Viruses (10/17/2006)
 

IDSA: HIV/HCV co-infection may lessen CD4 response to antiretroviral therapy  (10/13/2006)

 

IDSA: HIV/HCV co-infection may lessen CD4 response to antiretroviral therapy  (10/13/2006)

ICAAC: Clinical Significance of Occult HBV in People with HIV. (10/10/2006)

Overview of Antiretroviral Therapy for Patients with HIV-HBV Coinfection. (10/10/2006)
 

ICAAC: Clinical Significance of Occult HBV in People with HIV  (10/10/2006)

 

Overview of Antiretroviral Therapy for Patients with HIV-HBV Coinfection   (10/10/2006)
 

ICAAC: HIV/HCV co-infected patients respond to re-treatment with pegylated interferon plus ribavirin  (09/29/2006) 

 

ICAAC: Treatment of acute hepatitis C produces good response rates in HIV-positive patients  (09/29/2006)

 

GB Virus C Infection in HIV/HCV Coinfected Patients Receiving Hepatitis C Treatment (07/25/2006)
 

Insulin Resistance Not Linked with Fibrosis Progression in Coinfected Patients (07/25/2006)
 

Prolonged Treatment of HIV/HCV Coinfected Patients Without Early Virological Response (07/21/2006)
 

HCV Viral Load and Interferon Levels in HIV/HCV Coinfected Patients (07/21/2006)
 

Immunosuppression, Hepatitis C Infection, and Acute Renal Failure in HIV-Infected Patients - (07/06/2006)

 

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI or d4T cautiously'

 

DDW:  Growth factors vs. dose reduction for pegylated interferon alfa-2b and ribavirin-associated neutropenia and anemia in HIV/HCV co-infected patients  (06/06/2006)

 

Study finds steatosis (fatty liver) is more common & severe in HIV coinfected compared to HCV monoinfected  (06/06/2006)

 

Liver transplantation can be successful in patients co-infected with HIV and hepatitis B (05/4/2006)

 

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients - (05/17/2006)

 

In HIV/HCV-coinfected Patients, Normal ALT Levels Do Not Indicate Slower Fibrosis Progression
05/12/2006)

 

24 Weeks of HCV Treatment May Be Adequate for HIV Patients Coinfected with HCV genotype 2 or 3 (05/12/2006)

 

24 weeks of treatment may be sufficient for genotypes 2 & 3 in HIV/HCV if care is taken  (4-24-2006)

 

Unexpected interaction between heroin substitute and atazanavir/ritonavir (4-24-2006)

 

New Study Examines HAART Effects on HCV  (04/21/2006)

 

HIV/HCV coinfected may have worse survival as they spend less time on HAART (4/4/2006)

 

Caution Recommended in Use of Lopinavir/Ritonavir in HIV-HCV Coinfected Patients with Hepatic Impairment  (3/17/2006)

 

 

Promising data on consensus interferon in retreatment of relapsers and non-responders (06/09/2006)

 

 Eltrombopag improves thrombocytopenia in patients with cirrhosis (06/09/2006)

 

 Sexual dysfunction is highly prevalent among men with chronic hepatitis C negatively impacts health-related quality of life  (06/07/2006)

 

New findings suggest higher U.S. hepatitis C rate (06/06/2006)

 

Novartis strengthens infectious disease portfolio by acquiring rights to Albuferon(TM), a hepatitis C interferon drug set to enter Phase III trials  (06/06/2006)


 Peginterferon alfa-2a (Pegasys) and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response (06/06/2006)

 

 

 

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients 12/8/05

 

HCV & Coinfection-Expected Increased Hospitalizations Rates: complications expected to quadruple - (12/08/05)
 

Tenofovir Is Effective against HBV in HIV-HBV Coinfected Patients with or without Lamivudine-resistant HBV


Antiviral Response and Resistance Surveillance for HBeAg-negative Patients in a Study Evaluating Emtricitabine Plus Clevudine versus Emtricitabine Monotherapy
 

PK of Ribavirin & NRTIs in APRICOT Study

 

Hepatitis C found more frequently in semen of men coinfected with HIV/HCV

 

Buprenorphine Helps Combat Teen Heroin Addiction

 

Genital tract a 'sanctuary site' for hepatitis C virus in coinfected HIV-positive women

 

Increased Rates of Liver Cell Death in HCV/HIV Coinfection

 

Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients

 

Safety of EPZICOM (Abacavir + Lamivudine)-based HAART in ART-naïve HIV Positive Subjects with and without Hepatitis B and/or Hepatitis C Coinfection

 

Safety of LEXIVA (Fosamprenavir/Ritonavir)-containing Regimen Over 120 Weeks in HIV Positive Treatment-naïve Adults with or without hepatitis B and/or C Coinfection

 

Management of Hepatitis C and B in HIV-coinfected Individuals: An Overview of Studies Presented at the 3rd IAS Conference

 

 

HCV/HIV coinfection guidelines may lead to unnecessarily premature HAART discontinuation

 

 

Thinking Outside the Black Box: Toward Optimal


Treatment of Chronic Hepatitis B in HIV Patients

 

 

Very low rate of liver problems seen with Kaletra

 

 

HIV-positive patients coinfected with HCV up to 80% more likely to die even with HIV treatment

 

 

Safety of Abacavir + Lamivudine-based HAART in ART-naïve HIV Positive Subjects with and without Hepatitis B and/or Hepatitis C Coinfection

 

Epoetin Alfa Once Weekly Improves Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated With Interferon/Ribavirin: A Randomized Controlled Trial
 

Safety of Abacavir + Lamivudine-based HAART in ART-naïve HIV Positive Subjects with and without Hepatitis B and/or Hepatitis C Coinfection

 

Steatosis Is Less Common in HIV-HCV Coinfected Patients Than in Similar HCV-monoinfected Patients, and Predictors of Steatosis Differ between the Two Groups

 

Neuropsychological Aspects of Coinfection with HIV and Hepatitis C Virus

 

 

Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?

 

Rates of neuropsychological dysfunction such as memory loss, depression, anxiety, apathy, and fatigue, are elevated among persons infected with HIV, persons infected with HCV and coinfected persons

 

Lopinavir/ritonavir not linked to hepatotoxicity regardless of HCV status

 

Highlights of the 1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-infected Patients March 1 - 2, 2005, Paris, France

 

Overdose death more common amongst HIV-positive injecting drug users

 

HCV viremia means poorer immune response to HAART

 


Home | CME Zone | Hepatitis Education | Join Mailing List | About Us | News Archive | Site Map | Contact Us